BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Business

  Chindex International, Inc. to Report Second Quarter and First Half of 2013 Financial Results

  July 29, 2013

   · 

  1 min read
• Drug Development

  S1 Pharmaceuticals, Inc. Doses First Patients in Phase 2a Clinical Trial of Lorexys in Premenopausal Women With HSDD

  July 29, 2013

   · 

  5 min read
• Policy

  Anacor Pharmaceuticals, Inc. Announces That It Has Submitted a New Drug Application to the FDA for Tavaborole

  July 29, 2013

   · 

  1 min read
• Genetown

  Alere Inc.'s New, Independent Director Nominees Send Letter to Stockholders

  July 29, 2013

   · 

  2 min read
• Policy

  Actavis Confirms Generic Nucynta® ER Patent Challenge

  July 29, 2013

   · 

  3 min read
• Biotech Beach

  Simulations Plus Completes Molecule Design Phase of Second NCE Project, Issues RFQs for Molecule Synthesis

  July 29, 2013

   · 

  1 min read
• Biotech Bay

  Intuitive Surgical, Inc. Ups Share Buyback Program to $1.5 Billion and Uses $500 Million to Repurchase From Goldman, Sachs & Co.

  July 29, 2013

   · 

  5 min read
• Biotech Beach

  ReVision Optics, Inc. Closes $55 Million Financing

  July 29, 2013

   · 

  3 min read
• Business

  DURECT Corporation Invites You to Join its Second Quarter 2013 Earnings Conference Call

  July 29, 2013

   · 

  1 min read
• Drug Development

  BrainStorm Cell Therapeutics Inc.'s NurOwn Cell Therapy Receives Orphan Drug Designation in the European Union for ALS

  July 29, 2013

   · 

  3 min read